Take A Seat With Our Mike Patton
Here’s a sneak peek of one of the industry’s most reputable, hands-on trading programs with Mike Patton. Grab a free day pass to one of our live signal trading rooms today>>http://bit.ly/fb-free-pass
Read ArticleSign Up to Receive the Latest Trading Tips and News from Prosper
February 11, 2019
February 11, 2019
Not Great News For Vanda
Vanda Pharmaceuticals (VNDA) shares moved lower today after a negative report from market research firm Aurelius Value. Aurelius disclosed that it holds a short position in the stock, and alleges that VNDA’s CEO has engaged in fraudulent schemes along with his company as a whole. Here’s a recap.
Read Article
February 8, 2019
Learn About One Of the Market’s Hottest Markets With Mike Patton
Here’s a sneak peek of one of the industry’s most reputable, hands-on trading programs with Mike Patton. Grab a free day pass to one of our live signal trading rooms today>>http://bit.ly/fb-free-pass
Read Article
February 8, 2019
Muddy Waters Certainly Muddied the Waters For Inogen
Inogen Inc (INGN) shares were pressed lower in trading today after a negative report by short-seller Muddy Waters was published earlier today. The report alleged that the company’s management has inflated projections of future sales growth to its investors, thus pushing the stock price much higher than would be reasonable. The stock bounced back after […]
Read Article
February 7, 2019
Look Out Below For Sangamo Therapeutics
Sangamo Therapeutics (SGMO) shares slumped over -30% lower due to a failed Phase 1/2 study. The company reported its SB-318 genome editing product did not appear to show any clinical benefits. The company does have an extensive pipeline of treatments in clinical trials, as well as partnerships with major companies such as Pfizer. However, this […]
Read Article
February 5, 2019
Evolus, Part II
Evolus, Inc. (EOLS) is up again today following FDA approval of its first product, Jeuveau, on Friday. The stock was up over 25% at the time this content was recorded. Part of this rally is likely due to the fact that the stock had a large percentage of short positions. In fact, nearly a fifth […]
Read Article
February 4, 2019
Did Evolus Just Find the Fountain Of Youth?
Evolus Inc (EOLS) shares are up sharply today after the company gained FDA approval for their flagship product, Jeuveau, a cosmetic injection used to reduce the appearance of wrinkles on the face. This means Jeuveau is a direct competitor to Botox, which of course is a big seller for its parent company, Allergan. Here’s a […]
Read Article
February 1, 2019
Did AEVI Genomic Medicine Find An Angel Investor?
AEVI Genomic Medicine (GNMX) was active in trading today. While the reason for the bump in activity is not immediately evident, it is possibly related to potential developments with the company’s pipeline research, including possible additional investment to keep the company sufficiently funded to complete its current research for one of its products. The company’s […]
Read Article
January 31, 2019
Meet Prosper Trading Academy’s Mike Patton
Here’s a sneak peek of one of the industry’s most reputable, hands-on trading programs with Mike Patton. Grab a free day pass to one of our live signal trading rooms today>>http://bit.ly/fb-free-pass
Read Article
January 31, 2019
You Want Volume? Here’s Some Volume!
Histogenics Corporation (HSGX) shares rallied strongly today. The stock traded nearly 32 million shares as of 2 PM EST, and could potentially exceed 40 million shares by the close. As of the time this content was created, the stock was up over 36%. It is not immediately clear why shares are moving today, but I […]
Read Article
